A factory operated by Indorama Ventures. (Photo: Indorama Ventures)
Indorama Ventures Public Company Limited, the acquisitive Thai chemicals company, is considering a United States initial public offering of its integrated oxides and derivatives business that could raise about US$1 billion, according to people familiar with the matter.
The Bangkok-listed firm is working with financial advisers on the potential share sale, which could take place as soon as this year, the people said, asking not to be identified because the matter is private. The proceeds could help Indorama boost growth as well as reduce debt, the people said.
Considerations are at an early stage and Indorama could decide against pursuing a deal, the people said….
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
